Norton Children’s names new pediatric cancer chief
Norton Children’s has named a new physician to lead its cancer institute. Michael J. Ferguson, M.D., will serve as chief of Norton Children’s Cancer Institute and division chief of the University of Louisville School of […]
View moreThe acute lymphoblastic leukemia link to obesity
Survivors of the most common childhood cancer, acute lymphoblastic leukemia (ALL), need long-term monitoring for obesity and other ongoing health consequences of their disease and treatment. “The etiology of obesity among ALL survivors is not […]
View moreImmunotherapy for refractory B-cell acute lymphoblastic leukemia
The five-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has reached about 90% with chemotherapy. Clinicians increasingly are turning to immunotherapy for relapsed/refractory B-cell ALL (B-ALL). Immunotherapy harnesses the innate power [...]
View moreReduced-toxicity myeloablative conditioning regimen effective against high-risk pediatric leukemias
A low-toxicity myeloablative conditioning regimen is safe and effective in treating high-risk leukemias, particularly myeloid disease, according to a study recently published in the journal Pediatric Blood & Cancer. Conventional myeloablative conditioning is effective at […]
View moreIdentifying common bleeding disorders in pediatric patients
Signs of common bleeding disorders in children can take many forms from birth through adolescence, according to Ashok B. Raj, M.D., pediatric hematologist/oncologist with Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine. […]
View moreHemlibra revolutionizing care for pediatric hemophilia A patients
A new drug has revolutionized the care of children with moderate to severe hemophilia A, not only dramatically improving their quality of life but potentially eliminating future complications from the disease. Hemophilia A affects 1 […]
View moreCoordinating sickle cell disease care for a lifetime
Patients with sickle cell disease (SCD) are at high risk for a broad range of acute and chronic conditions affecting many of the body’s systems and carrying a high association with morbidity. Given the broad […]
View moreJun Zhao, D.O., named physician lead for outpatient care at Norton Children’s Cancer Institute
Jun Zhao, D.O., pediatric hematologist/oncologist, has been named physician lead for outpatient care at Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine. Dr. Zhao will work with Ashok B. Raj, M.D., medical […]
View moreErythrocytapheresis minimizes iron load and improves growth in sickle cell patients
Erythrocytapheresis (automated red cell exchange) increasingly is used to replace sickled red cells in sickle cell disease (SCD) patients as an alternative to transfusion. The procedure doesn’t significantly raise the total hemoglobin — a frequent […]
View moreSunnye Mayes, Ph.D. ABPP, joins Norton Children’s Cancer Institute as hematology/oncology psychologist
Sunnye Mayes, Ph.D. ABPP, has joined Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, as hematology/oncology psychologist. Dr. Mayes is the only provider in Kentucky or Southern Indiana certified by the American […]
View moreDiagnosing HLH can be difficult, but rapid treatment can be effective
Because it is rare and has varied symptoms, hemophagocytic lymphohistiocytosis (HLH) can be difficult to diagnose. Without quick diagnosis and timely HLH treatment, however, it can be life-threatening. HLH can be inherited (primary or familial […]
View moreFinding a path to medicine as a pediatric leukemia patient
Bradley Wilson’s journey to medical school started in the Norton Children’s Hospital emergency department when he was 13. Unable to walk, losing consciousness and with his skin grayish, Bradley was rushed by his parents to […]
View more